Florence Rigal

Senior Manager Regulatory Affairs at Baxter International Inc.

Brussels Metropolitan Area

About

Experience

  • Baxter International Inc. (Full-time · 13 yrs 6 mos)
    • Senior Manager Regulatory Affairs
      Mar 2024 - Present · 2 yrs 4 mos

      Global Regulatory Lead in Clinical Nutrition Therapeutic Area: - Develop and execute regulatory plans for complex projects including new product development and lifecycle management of sterile drug products - Represent the RA function on assigned cross-functional project teams for the portfolio - From 2025 to 2026, actively participated in implementation of Veeva Vault RIM Suite for IDMP implementation

    • Senior Manager Regulatory Affairs
      Jan 2020 - Feb 2024 · 4 yrs 2 mos

      Global Regulatory Lead in Clinical Nutrition Therapeutic Area, in charge of the Devices group for Electromechanical, Software and Disposable products: - Develop and execute regulatory plans for complex projects including new product development, EU Medical Device Regulation (MDR) and CE-marking of non-Medical Device equipment - Represent the RA function on assigned cross-functional project teams for the portfolio - Oversee group activities, project assignment and prioritization - From 2020 to 2023, actively participated in implementation of Veeva Vault RIM Suite (Registrations, Submissions and Submission Archives), migration of existing data from Register and FirstDoc to Veeva Vault, development of internal processes and best practices for international adoption by the RA community and supporting functions

    • Senior Manager Regulatory Affairs
      May 2019 - Jan 2020 · 9 mos

      Global Regulatory Lead in Clinical Nutrition Therapeutic Area, in charge of the Micronutrients and Devices group: - Develop and execute regulatory plans for complex projects including new product registration and maintenance of licenses - Represent or lead the RA function on assigned cross-functional project teams - Oversee group activities, project assignment and prioritization

  • Specialist Regulatory Affairs at Aptalis Pharma (formerly Axcan Pharma; subsidiary of Actavis)
    Jun 2009 - Jan 2013 · 3 yrs 8 mos

    - Clinical trial regulatory submissions in EU (Phase III-IV) - Lifecycle management of biological product family in Europe, CIS and Central & South America - CMC compliance - Development and implementation of a process for EU xEVMPD data collection and upload into EMA's database

  • Specialist Regulatory Affairs at Advanced Accelerator Applications
    Aug 2007 - May 2009 · 1 yr 10 mos

    - Registration of a radiopharmaceutical product through a European Decentralised Procedure - Adapting Quality/CMC documentation from US dossier (NDA and SNDA) to CTD format for EU - Lifecycle management of a radiopharmaceutical product registered via European Mutual Recognition Procedure - Insourcing of eCTD publishing (using eCTD Office) and development of eCTD-compliant templates

  • Regulatory Affairs Intern at SGS
    Jan 2006 - Mar 2006 · 3 mos

    Research question: What are the REACH Regulation proposal and its impact for the industry? ­- Analysis of the draft Regulation proposal ­- Authoring of flowcharts breaking down the different decision trees, processes, and related actions described in the draft Regulation ­- Creation of a bilingual (French-English) web-interface to facilitate the navigation between created flowcharts, summaries of important items and full regulatory texts.